Skip to main content
Premium Trial:

Request an Annual Quote

ArraGen Selects BioDiscovery s GeneDirector Software

NEW YORK, Feb. 3 (GenomeWeb News) - ArraGen of Craigavon, Northern Ireland, will use BioDiscovery's GeneDirector enterprise software to manage its microarray data, BioDiscovery said today.


ArraGen, a new company developing microarray-based cancer diagnostics, said it will use the software to manage and analyze gene expression data from the Affymetrix GeneChip platform.


Financial terms of the agreement were not provided.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.